BIOLASE to Present at the 29th Annual ROTH Conference
IRVINE, Calif.--(BUSINESS WIRE)-- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that President and CEO Harold C. Flynn, Jr. is scheduled to present at the 29th Annual ROTH Conference on Tuesday, March 14, at 8:00 am Pacific Time. The conference is being held at the Ritz-Carlton in Dana Point, CA on March 13-15.
A live webcast of the presentation will be available on the Investor Events page of the Investors section of BIOLASE’s website at www.biolase.com.
About BIOLASE, Inc.
BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including digital x-rays and CAD/CAM scanners. BIOLASE’s products are focused on technologies that advance the practice of dentistry to both dentists and their patients. BIOLASE's proprietary laser products incorporate approximately 230 patented and 85 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold approximately 33,600 laser systems to date in over 90 countries around the world. Laser products under development address BIOLASE’s core dental market and other adjacent medical and consumer markets.
For updates and information on Waterlase® iPlus™ and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, LinkedIn at www.linkedin.com/company/biolase, and YouTube at www.youtube.com/biolasevideos.
BIOLASE® and Waterlase® are registered trademarks of BIOLASE, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170309005370/en/
DresnerAllenCaron
Michael Mason (Investors)
212-691-8087
mmason@dresnerallencaron.com
or
Rene
Caron (Investors)
rcaron@dresnerallencaron.com
or
Len
Hall (Media)
949-474-4300
lhall@dresnerallencaron.com
Source: BIOLASE, Inc.
Released March 9, 2017
